BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

160 related articles for article (PubMed ID: 33368684)

  • 41. Identification of cysteinyl-leukotriene-receptor 1 antagonists as ligands for the bile acid receptor GPBAR1.
    Biagioli M; Carino A; Marchianò S; Roselli R; Di Giorgio C; Bordoni M; Fiorucci C; Sepe V; Conflitti P; Limongelli V; Distrutti E; Baldoni M; Zampella A; Fiorucci S
    Biochem Pharmacol; 2020 Jul; 177():113987. PubMed ID: 32330496
    [TBL] [Abstract][Full Text] [Related]  

  • 42. FXR-dependent reduction of hepatic steatosis in a bile salt deficient mouse model.
    Kunne C; Acco A; Duijst S; de Waart DR; Paulusma CC; Gaemers I; Oude Elferink RP
    Biochim Biophys Acta; 2014 May; 1842(5):739-46. PubMed ID: 24548803
    [TBL] [Abstract][Full Text] [Related]  

  • 43. The Pharmacology of Bile Acids and Their Receptors.
    Fiorucci S; Distrutti E
    Handb Exp Pharmacol; 2019; 256():3-18. PubMed ID: 31201555
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Navigation in bile acid chemical space: discovery of novel FXR and GPBAR1 ligands.
    Finamore C; Festa C; Renga B; Sepe V; Carino A; Masullo D; Biagioli M; Marchianò S; Capolupo A; Monti MC; Fiorucci S; Zampella A
    Sci Rep; 2016 Jul; 6():29320. PubMed ID: 27381677
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Bile acid-activated receptors and the regulation of macrophages function in metabolic disorders.
    Fiorucci S; Baldoni M; Ricci P; Zampella A; Distrutti E; Biagioli M
    Curr Opin Pharmacol; 2020 Aug; 53():45-54. PubMed ID: 32480317
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Regulation of Liver Energy Balance by the Nuclear Receptors Farnesoid X Receptor and Peroxisome Proliferator Activated Receptor α.
    Kim KH; Moore DD
    Dig Dis; 2017; 35(3):203-209. PubMed ID: 28249296
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Bile Acids Activated Receptors Regulate Innate Immunity.
    Fiorucci S; Biagioli M; Zampella A; Distrutti E
    Front Immunol; 2018; 9():1853. PubMed ID: 30150987
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Activation of GPBAR1 attenuates vascular inflammation and atherosclerosis in a mouse model of NAFLD-related cardiovascular disease.
    Biagioli M; Marchianò S; Di Giorgio C; Bordoni M; Urbani G; Bellini R; Massa C; Sami Ullah Khan R; Roselli R; Chiara Monti M; Morretta E; Giordano A; Vellecco V; Bucci M; Jilani Iqbal A; Saviano A; Ab Mansour A; Ricci P; Distrutti E; Zampella A; Cieri E; Cirino G; Fiorucci S
    Biochem Pharmacol; 2023 Dec; 218():115900. PubMed ID: 37926268
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Glucocorticoid receptor mediates the gluconeogenic activity of the farnesoid X receptor in the fasting condition.
    Renga B; Mencarelli A; D'Amore C; Cipriani S; Baldelli F; Zampella A; Distrutti E; Fiorucci S
    FASEB J; 2012 Jul; 26(7):3021-31. PubMed ID: 22447981
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Ursodeoxycholic Acid Suppresses Lipogenesis in Mouse Liver: Possible Role of the Decrease in β-Muricholic Acid, a Farnesoid X Receptor Antagonist.
    Fujita K; Iguchi Y; Une M; Watanabe S
    Lipids; 2017 Apr; 52(4):335-344. PubMed ID: 28315136
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Farnesoid X Receptor Activation Promotes Hepatic Amino Acid Catabolism and Ammonium Clearance in Mice.
    Massafra V; Milona A; Vos HR; Ramos RJJ; Gerrits J; Willemsen ECL; Ramos Pittol JM; Ijssennagger N; Houweling M; Prinsen HCMT; Verhoeven-Duif NM; Burgering BMT; van Mil SWC
    Gastroenterology; 2017 May; 152(6):1462-1476.e10. PubMed ID: 28130067
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Signaling from Intestine to the Host: How Bile Acids Regulate Intestinal and Liver Immunity.
    Biagioli M; Carino A
    Handb Exp Pharmacol; 2019; 256():95-108. PubMed ID: 31119464
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Bile acid signaling through FXR induces intracellular adhesion molecule-1 expression in mouse liver and human hepatocytes.
    Qin P; Borges-Marcucci LA; Evans MJ; Harnish DC
    Am J Physiol Gastrointest Liver Physiol; 2005 Aug; 289(2):G267-73. PubMed ID: 15817812
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Intestine-selective farnesoid X receptor inhibition improves obesity-related metabolic dysfunction.
    Jiang C; Xie C; Lv Y; Li J; Krausz KW; Shi J; Brocker CN; Desai D; Amin SG; Bisson WH; Liu Y; Gavrilova O; Patterson AD; Gonzalez FJ
    Nat Commun; 2015 Dec; 6():10166. PubMed ID: 26670557
    [TBL] [Abstract][Full Text] [Related]  

  • 55. [What the (abdominal) surgeon needs to know on novel insights regarding cholic acids and their interaction with the intestinal microbioma].
    Schönfeld P; Meyer F
    Z Gastroenterol; 2020 Mar; 58(3):245-253. PubMed ID: 32018318
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Role of nuclear receptors and hepatocyte-enriched transcription factors for Ntcp repression in biliary obstruction in mouse liver.
    Zollner G; Wagner M; Fickert P; Geier A; Fuchsbichler A; Silbert D; Gumhold J; Zatloukal K; Kaser A; Tilg H; Denk H; Trauner M
    Am J Physiol Gastrointest Liver Physiol; 2005 Nov; 289(5):G798-805. PubMed ID: 16002565
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Bile salt excretory pump: biology and pathobiology.
    Suchy FJ; Ananthanarayanan M
    J Pediatr Gastroenterol Nutr; 2006 Jul; 43 Suppl 1():S10-6. PubMed ID: 16819395
    [TBL] [Abstract][Full Text] [Related]  

  • 58. The bile acid receptor GPBAR1 (TGR5) is expressed in human gastric cancers and promotes epithelial-mesenchymal transition in gastric cancer cell lines.
    Carino A; Graziosi L; D'Amore C; Cipriani S; Marchianò S; Marino E; Zampella A; Rende M; Mosci P; Distrutti E; Donini A; Fiorucci S
    Oncotarget; 2016 Sep; 7(38):61021-61035. PubMed ID: 27409173
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Bile Acid G Protein-Coupled Membrane Receptor TGR5 Modulates Aquaporin 2-Mediated Water Homeostasis.
    Li S; Qiu M; Kong Y; Zhao X; Choi HJ; Reich M; Bunkelman BH; Liu Q; Hu S; Han M; Xie H; Rosenberg AZ; Keitel V; Kwon TH; Levi M; Li C; Wang W
    J Am Soc Nephrol; 2018 Nov; 29(11):2658-2670. PubMed ID: 30305310
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Hepatic Autophagy Deficiency Compromises Farnesoid X Receptor Functionality and Causes Cholestatic Injury.
    Khambu B; Li T; Yan S; Yu C; Chen X; Goheen M; Li Y; Lin J; Cummings OW; Lee YA; Friedman S; Dong Z; Feng GS; Wu S; Yin XM
    Hepatology; 2019 May; 69(5):2196-2213. PubMed ID: 30520052
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.